{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260429582815/en/U.S.-FDA-Grants-Priority-Review-to-BeOne-Medicines%E2%80%99-TEVIMBRA-in-First-Line-HER2-GEA", "message": "News view counter 688057 successfully enlarged"}